GGrantIndex
← Search

TEVETEN PLUS ENALAPRIL VERSUS PLACEBO IN AFRICAN AMERICAN PATIENTS W/HYPERTENSION

$0M01FY2001RRNIH

Brigham And Women'S Hospital, Boston MA

Investigators

Linked publications & trials

Abstract

To compare the antihypertensive efficacy of Tevetan at an initial dose of 600mg once daily and a forced -titration dose of 1200mg once daily to placebo in African American with essential hypertension during ususal salt intake.

View original record on NIH RePORTER →